Literature DB >> 29454929

HuR-mediated SCN5A messenger RNA stability reduces arrhythmic risk in heart failure.

Anyu Zhou1, An Xie2, Tae Yun Kim1, Hong Liu2, Guangbin Shi1, Gyeoung-Jin Kang3, Ning Jiang1, Man Liu2, Euy-Myoung Jeong1, Bum-Rak Choi1, Samuel C Dudley4.   

Abstract

BACKGROUND: Downregulated sodium currents in heart failure (HF) have been linked to increased arrhythmic risk. Reduced expression of the messenger RNA (mRNA)-stabilizing protein HuR (also known as ELAVL1) may be responsible for the downregulation of sodium channel gene SCN5A mRNA.
OBJECTIVE: The purpose of this article was to investigate whether HuR regulates SCN5A mRNA expression and whether manipulation of HuR benefits arrhythmia control in HF.
METHODS: Quantitative real-time reverse-transcriptase polymerase chain reaction was used to investigate the expression of SCN5A. Optical mapping of the intact heart was adopted to study the effects of HuR on the conduction velocity and action potential upstroke in mice with myocardial infarct and HF after injection of AAV9 viral particles carrying HuR.
RESULTS: HuR was associated with SCN5A mRNA in cardiomyocytes, and expression of HuR was downregulated in failing hearts. The association of HuR and SCN5A mRNA protected SCN5A mRNA from decay. Injection of AAV9 viral particles carrying HuR increased SCN5A expression in mouse heart tissues after MI. Optical mapping of the intact heart demonstrated that overexpression of HuR improved action potential upstroke and conduction velocity in the infarct border zone, which reduced the risk of reentrant arrhythmia after MI.
CONCLUSION: Our data indicate that HuR is an important RNA-binding protein in maintaining SCN5A mRNA abundance in cardiomyocytes. Reduced expression of HuR may be at least partially responsible for the downregulation of SCN5A mRNA expression in ischemic HF. Overexpression of HuR may rescue decreased SCN5A expression and reduce arrhythmic risk in HF. Increasing mRNA stability to increase ion channel currents may correct a fundamental defect in HF and represent a new paradigm in antiarrhythmic therapy.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Cardiac sodium channel; Heart failure; RNA-binding protein; mRNA decay

Mesh:

Substances:

Year:  2018        PMID: 29454929      PMCID: PMC6026071          DOI: 10.1016/j.hrthm.2018.02.018

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  26 in total

1.  Hallmarks of ion channel gene expression in end-stage heart failure.

Authors:  Jürgen Borlak; Thomas Thum
Journal:  FASEB J       Date:  2003-09       Impact factor: 5.191

Review 2.  Modulation of mRNA stability as a novel therapeutic approach.

Authors:  Wolfgang Eberhardt; Anke Doller; El-Sayed Akool; Josef Pfeilschifter
Journal:  Pharmacol Ther       Date:  2007-01-25       Impact factor: 12.310

3.  Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR.

Authors:  El-Sayed Akool; Hartmut Kleinert; Farid M A Hamada; Mohamed H Abdelwahab; Ulrich Förstermann; Josef Pfeilschifter; Wolfgang Eberhardt
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

4.  c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction.

Authors:  Cody A Rutledge; Fu Siong Ng; Matthew S Sulkin; Ian D Greener; Artem M Sergeyenko; Hong Liu; Joanna Gemel; Eric C Beyer; Ali A Sovari; Igor R Efimov; Samuel C Dudley
Journal:  J Am Coll Cardiol       Date:  2014-01-08       Impact factor: 24.094

5.  Berberine Decreased Inducible Nitric Oxide Synthase mRNA Stability through Negative Regulation of Human Antigen R in Lipopolysaccharide-Induced Macrophages.

Authors:  Ji-Sun Shin; Hye-Eun Choi; SeungHwan Seo; Jung-Hye Choi; Nam-In Baek; Kyung-Tae Lee
Journal:  J Pharmacol Exp Ther       Date:  2016-05-12       Impact factor: 4.030

Review 6.  Adaptive and maladaptive expression of the mRNA regulatory protein HuR.

Authors:  Suman Govindaraju; Beth S Lee
Journal:  World J Biol Chem       Date:  2013-11-26

7.  Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome.

Authors:  Ohad Ziv; Eduardo Morales; Yoon-kyu Song; Xuwen Peng; Katja E Odening; Alfred E Buxton; Alain Karma; Gideon Koren; Bum-Rak Choi
Journal:  J Physiol       Date:  2009-08-12       Impact factor: 5.182

8.  Enhanced risk profiling of implanted defibrillator shocks with circulating SCN5A mRNA splicing variants: a pilot trial.

Authors:  Ge Gao; Vikram Brahmanandam; Mihai Raicu; Lianzhi Gu; Li Zhou; Srinivasan Kasturirangan; Anish Shah; Smita I Negi; Melissa R Wood; Ankit A Desai; Antone Tatooles; Alan Schwartz; Samuel C Dudley
Journal:  J Am Coll Cardiol       Date:  2014-04-02       Impact factor: 24.094

9.  Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability.

Authors:  Neelanjan Mukherjee; David L Corcoran; Jeffrey D Nusbaum; David W Reid; Stoyan Georgiev; Markus Hafner; Manuel Ascano; Thomas Tuschl; Uwe Ohler; Jack D Keene
Journal:  Mol Cell       Date:  2011-06-30       Impact factor: 17.970

10.  Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.

Authors:  A B Katwal; P R Konkalmatt; B A Piras; S Hazarika; S S Li; R John Lye; J M Sanders; E A Ferrante; Z Yan; B H Annex; B A French
Journal:  Gene Ther       Date:  2013-03-28       Impact factor: 5.250

View more
  8 in total

Review 1.  Cardiovascular inflammation: RNA takes the lead.

Authors:  Colton R Martens; Shyam S Bansal; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000

Review 2.  Preventing unfolded protein response-induced ion channel dysregulation to treat arrhythmias.

Authors:  Man Liu; Gyeoung-Jin Kang; Samuel C Dudley
Journal:  Trends Mol Med       Date:  2022-04-10       Impact factor: 15.272

3.  HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetes.

Authors:  Rui Si; Jody Tori O Cabrera; Atsumi Tsuji-Hosokawa; Rui Guo; Makiko Watanabe; Lei Gao; Yun Sok Lee; Jae-Su Moon; Brian T Scott; Jian Wang; Anthony W Ashton; Jaladanki N Rao; Jian-Ying Wang; Jason X-J Yuan; Ayako Makino
Journal:  JCI Insight       Date:  2021-11-08

Review 4.  Genomic and Non-Genomic Regulatory Mechanisms of the Cardiac Sodium Channel in Cardiac Arrhythmias.

Authors:  Houria Daimi; Estefanía Lozano-Velasco; Amelia Aranega; Diego Franco
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

5.  Inhibition of the unfolded protein response reduces arrhythmia risk after myocardial infarction.

Authors:  Man Liu; Hong Liu; Preethy Parthiban; Gyeoung-Jin Kang; Guangbin Shi; Feng Feng; Anyu Zhou; Lianzhi Gu; Courtney Karnopp; Elena G Tolkacheva; Samuel C Dudley
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

Review 6.  SCN5A Variants: Association With Cardiac Disorders.

Authors:  Wenjia Li; Lei Yin; Cheng Shen; Kai Hu; Junbo Ge; Aijun Sun
Journal:  Front Physiol       Date:  2018-10-09       Impact factor: 4.566

7.  MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel.

Authors:  Gyeoung-Jin Kang; An Xie; Hong Liu; Samuel C Dudley
Journal:  JCI Insight       Date:  2020-12-03

Review 8.  mRNA Metabolism in Cardiac Development and Disease: Life After Transcription.

Authors:  Chen Gao; Yibin Wang
Journal:  Physiol Rev       Date:  2019-11-21       Impact factor: 37.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.